Asensus Surgical Inc (ASXC) Stock Price, Quote, News and Overview
NYSEARCA:ASXC - NYSE Arca - US04367G1031 - Common Stock - Currency: USD
ASXC Quote, Performance and Key Statistics
0.3479
+0 (+0.64%)
The current stock price of ASXC is 0.3479 USD. In the past month the price increased by 2.9%. In the past year, price increased by 23.37%.
ASXC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.16 | 225.18B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.87 | 174.81B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.41 | 146.31B | ||
| SYK | STRYKER CORP | 29.3 | 136.31B | ||
| MDT | MEDTRONIC PLC | 15.68 | 107.41B | ||
| BDX | BECTON DICKINSON AND CO | 14.54 | 58.09B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.89 | 41.42B | ||
| IDXX | IDEXX LABORATORIES INC | 37.92 | 34.57B | ||
| RMD | RESMED INC | 24.26 | 31.49B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.45 | 29.71B | ||
| DXCM | DEXCOM INC | 40.52 | 26.22B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.38 | 22.99B |
Related stock screener links
About ASXC
Company Profile
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 207 full-time employees. The company operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. The company is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The company is also working to incorporate all of this in the LUNA Surgical System.
Company Info
Asensus Surgical Inc
1 Tw Alexander Drive, Suite 160
Durham NORTH CAROLINA 27703 US
CEO: Anthony Fernando
Employees: 207
Company Website: https://asensus.com/
Phone: 19197658400
Asensus Surgical Inc / ASXC FAQ
What is the stock price of Asensus Surgical Inc today?
The current stock price of ASXC is 0.3479 USD. The price increased by 0.64% in the last trading session.
What is the ticker symbol for Asensus Surgical Inc stock?
The exchange symbol of Asensus Surgical Inc is ASXC and it is listed on the NYSE Arca exchange.
On which exchange is ASXC stock listed?
ASXC stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for Asensus Surgical Inc stock?
7 analysts have analysed ASXC and the average price target is 0.36 USD. This implies a price increase of 2.62% is expected in the next year compared to the current price of 0.3479. Check the Asensus Surgical Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Asensus Surgical Inc worth?
Asensus Surgical Inc (ASXC) has a market capitalization of 94.62M USD. This makes ASXC a Micro Cap stock.
How many employees does Asensus Surgical Inc have?
Asensus Surgical Inc (ASXC) currently has 207 employees.
What are the support and resistance levels for Asensus Surgical Inc (ASXC) stock?
Asensus Surgical Inc (ASXC) has a support level at 0.29. Check the full technical report for a detailed analysis of ASXC support and resistance levels.
Is Asensus Surgical Inc (ASXC) expected to grow?
The Revenue of Asensus Surgical Inc (ASXC) is expected to grow by 43.58% in the next year. Check the estimates tab for more information on the ASXC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy Asensus Surgical Inc (ASXC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ASXC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ASXC, evaluating the profitability, health, valuation and growth aspects
- Asensus Surgical Inc (ASXC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Asensus Surgical Inc (ASXC) Sales and EPS estimates to see what analysts future expectations are.
- Asensus Surgical Inc (ASXC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Asensus Surgical Inc (ASXC) Insider and Institutional Ownership to learn about the owners and their transactions.
- Asensus Surgical Inc (ASXC) Stock Chart to make your own analysis
- Asensus Surgical Inc (ASXC) Latest news and press-releases to stay up to date.
Does Asensus Surgical Inc (ASXC) stock pay dividends?
ASXC does not pay a dividend.
When does Asensus Surgical Inc (ASXC) report earnings?
Asensus Surgical Inc (ASXC) will report earnings on 2024-11-12, after the market close.
What is the Price/Earnings (PE) ratio of Asensus Surgical Inc (ASXC)?
Asensus Surgical Inc (ASXC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
ASXC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ASXC. When comparing the yearly performance of all stocks, ASXC is one of the better performing stocks in the market, outperforming 91.45% of all stocks.
ASXC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ASXC. The financial health of ASXC is average, but there are quite some concerns on its profitability.
ASXC Financial Highlights
Over the last trailing twelve months ASXC reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 17.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -192.86% | ||
| ROE | -604.36% | ||
| Debt/Equity | 0 |
ASXC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to ASXC. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 21.03% and a revenue growth 43.58% for ASXC